Ragosa Markinsider trades
In SEC Form 4 filings, Ragosa Mark is listed as CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). Ragosa Mark reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| KNSAKiniksa Pharmaceuticals International, plc | CHIEF FINANCIAL OFFICER | 11 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 2,694 | not reported | not reported | 18,848 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 1,750 | not reported | not reported | 20,598 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 1,591 | not reported | not reported | 22,189 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 3,069 | not reported | not reported | 25,258 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | F | 4,404 | $79.28 | $349,149 | 20,854 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 7,800 | $0.00 | $0 | 7,800 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 31,150 | $79.28 | $2,469,572 | 31,150 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 3,069 | $0.00 | $0 | 9,206 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 1,591 | $0.00 | $0 | 3,182 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 1,750 | $0.00 | $0 | 1,750 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 2,694 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.